Clinical Trial Update: Mesenchymal Stem Cell Transplantation in MS [Phase 2]

View source ↗

Summary

Phase 2 study evaluating mesenchymal stem cell transplantation for multiple sclerosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Mesenchymal stem cell transplantation (mesenchymal stem cells)

Snippet

Sponsor: Albert Saiz | Conditions: Multiple Sclerosis | Phase 2 | Status: TERMINATED